| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf6edae5250129896be5ca2e33a61ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c20058bb6da89b118462ef2612b836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b840490ce4e7830aa852a942094b9df0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b680f557d78c03e6b798bdaf8d63002 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-70 |
| filingDate |
2010-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04513968ee1d28afa5e784f734fe5b14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30964b98024dee14f3af70b13c7076d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3afe209f0961dfe84c03ec31e3476830
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dcb632dc314afe5a15f019ed1f78e76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24dfc68058fd92e6ee1545c6acd0d8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2346e308be2a2f211787c4c2663b17fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8591acfc88b8ad50a6484bdad3a711d6 |
| publicationDate |
2012-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2442106-A1 |
| titleOfInvention |
Method for test on diabetic nephropathy |
| abstract |
Provided is a test method for the detection of diabetic nephropathy at an early stage as compared to a conventional method. Specifically provided are: a test method for diabetic nephropathy, including detecting urinary podocalyxin; the test method, further including assessing diabetic nephropathy at at least Stage I; a test reagent for use in the test method; and a test reagent kit for use in the test method. The present invention is based on a finding that urinary podocalyxin reflects the development and condition of diabetic nephropathy with high sensitivity at an early stage as compared to urinary albumin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3299819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107870240-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3299820-A1 |
| priorityDate |
2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |